|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
almost 15 years ago
Plant Managementalmost 15 years ago
The Road from No. 20almost 15 years ago
Five Yearsalmost 15 years ago
Spotlight on OTCsalmost 15 years ago
Invaralmost 15 years ago
Europe Tackles 'Advertising in Disguise' Fearsalmost 15 years ago
The Drug Shortages Strugglealmost 15 years ago
Euroservicealmost 15 years ago
Pharma's Visit to the Plastic Surgeonalmost 15 years ago
The Pharma Revolution RecalibratedAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5